TNPO2
Basic information
Region (hg38): 19:12699201-12724011
Links
Phenotypes
GenCC
Source:
- intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (Strong), mode of inheritance: AD
- intellectual disability (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | AD | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic; Renal | 34314705 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNPO2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 39 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
splice region | 5 | 3 | 8 | |||
non coding | 0 | |||||
Total | 0 | 10 | 44 | 7 | 4 |
Variants in TNPO2
This is a list of pathogenic ClinVar variants found in the TNPO2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-12701363-C-T | Inborn genetic diseases | Uncertain significance (Sep 14, 2022) | ||
19-12701386-G-A | Inborn genetic diseases | Likely benign (Dec 17, 2023) | ||
19-12701444-C-T | Inborn genetic diseases | Uncertain significance (May 06, 2024) | ||
19-12701448-G-A | Benign/Likely benign (Oct 01, 2024) | |||
19-12701609-T-G | Inborn genetic diseases | Uncertain significance (Jul 12, 2023) | ||
19-12701679-C-T | not specified | Uncertain significance (Mar 13, 2024) | ||
19-12701799-G-A | TNPO2-related disorder | Likely benign (Aug 28, 2024) | ||
19-12701851-CC-AG | Uncertain significance (Jun 01, 2023) | |||
19-12701867-C-A | not specified | Likely benign (Dec 29, 2024) | ||
19-12702141-G-A | Likely pathogenic (May 15, 2022) | |||
19-12702168-G-A | Benign (Feb 20, 2018) | |||
19-12702174-C-T | Inborn genetic diseases | Likely benign (Sep 26, 2022) | ||
19-12702920-T-C | Uncertain significance (Jul 11, 2024) | |||
19-12703514-G-T | Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | Uncertain significance (Dec 28, 2023) | ||
19-12703709-C-T | TNPO2-related disorder | Likely benign (Sep 10, 2024) | ||
19-12703710-G-A | TNPO2-related disorder | Likely benign (Jun 15, 2022) | ||
19-12703713-C-G | Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | Likely pathogenic (Jan 03, 2022) | ||
19-12703720-A-T | TNPO2-related disorder | Uncertain significance (Apr 24, 2024) | ||
19-12703730-A-G | Benign (Jul 04, 2018) | |||
19-12703765-G-A | Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | Uncertain significance (Apr 20, 2022) | ||
19-12703765-G-T | Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | Uncertain significance (Jan 01, 2023) | ||
19-12703776-C-G | Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies | Likely pathogenic (Oct 28, 2021) | ||
19-12705277-C-T | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
19-12705288-C-G | Inborn genetic diseases | Conflicting classifications of pathogenicity (Sep 04, 2024) | ||
19-12705325-C-T | Uncertain significance (Mar 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNPO2 | protein_coding | protein_coding | ENST00000425528 | 23 | 24818 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 6.13e-7 | 124634 | 0 | 5 | 124639 | 0.0000201 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 5.88 | 152 | 534 | 0.284 | 0.0000319 | 5910 |
Missense in Polyphen | 11 | 100.52 | 0.10943 | 1193 | ||
Synonymous | -0.146 | 235 | 232 | 1.01 | 0.0000159 | 1714 |
Loss of Function | 6.20 | 2 | 48.6 | 0.0411 | 0.00000226 | 545 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000358 | 0.0000354 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probably functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.55
Haploinsufficiency Scores
- pHI
- 0.533
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.717
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.747
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnpo2
- Phenotype
Gene ontology
- Biological process
- NLS-bearing protein import into nucleus;ribosomal protein import into nucleus
- Cellular component
- nucleus;cytoplasm;nuclear membrane;nuclear periphery
- Molecular function
- protein binding;nuclear localization sequence binding;Ran GTPase binding;protein transporter activity